Streetbeat News

Products Services

ASLN

ASLAN Pharmaceuticals announced that its 600mg Eblasakimab, dosed once every four weeks in the TREK-AD study, met the primary endpoint with statistical significance.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:57 am

QCOM

Samsung is offering a $50 credit on pre-orders of its upcoming foldable phones, the Galaxy Z Fold 5 and the Galaxy Z Flip 5, set to launch on July 26. The Galaxy Z Flip 5, which has received increased attention from Samsung and Google, is rumored to feature a Qualcomm Inc.'s Snapdragon 8 Gen 2 chipset.

Portfolio Pulse from Rounak Jain

July 06, 2023 | 11:55 am

STSS

Sharps Technology, Inc. (NASDAQ: STSS and STSSW), a medical device and drug delivery company, has been featured in Med Tech Outlook as the 'Top Safety Syringe Manufacturer in 2023'. The company is advancing its products from research and development to commercial sales, expected to launch in 2023. The article also highlights Sharps' partnership with Nephron Pharmaceuticals and its next-generation polymer-based prefillable syringe systems.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:53 am

BABA

MSFT

NVDA

Alibaba Group Holding Limited (NYSE:BABA) is partnering with Zhejiang province to develop artificial intelligence and the digital economy. The collaboration aims to create a better business environment for platform-economy firms and encourage innovations in AI. Alibaba is integrating its large language model across its business lines to improve user experience. Nvidia Corp (NASDAQ:NVDA) and Microsoft Corp (NASDAQ:MSFT) highlighted the benefits of generative AI during an Alibaba summit in June.

Portfolio Pulse from Anusuya Lahiri

July 06, 2023 | 11:52 am

LLY

The New England Journal of Medicine has published detailed results from the BRUIN Phase 1/2 trial evaluating the efficacy and safety of pirtobrutinib, a drug under investigation by Eli Lilly. The drug, a non-covalent Bruton's tyrosine kinase inhibitor, is being tested in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were previously treated with a BTK inhibitor.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:47 am

META

Meta Platforms has launched its Threads platform, a competitor to Twitter, causing its shares to trade higher. KeyBanc also raised its price target for Meta from $280 to $335.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:47 am

EADSY

RTX

Airbus SE has signed a memorandum of understanding with Mexican airline Viva Aerobus for 90 A321neo aircraft. The planes will be powered by Pratt & Whitney GTF engines, a unit of Raytheon Technologies Corporation. The order is expected to be delivered by 2027. The financial terms were not disclosed.

Portfolio Pulse from Nabaparna Bhattacharya

July 06, 2023 | 11:41 am

PSNY

Polestar, the electric vehicle manufacturer, is reportedly on track to deliver between 60,000 to 70,000 vehicles in 2023.

Portfolio Pulse from Charles Gross

July 06, 2023 | 11:35 am

VEEV

Veeva Systems has partnered with St. Cloud State University to provide medtech clinical research students with hands-on technology training. This partnership aims to equip students with practical skills and knowledge in the medtech industry.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:07 am

GDTC

CytoMed Therapeutics Limited (NASDAQ:GDTC), a Singapore-based biopharmaceutical company, has been granted a patent by the US Patent and Trademark Office for its CAR-gamma delta T cell technology, which it has exclusively licensed from A*STAR.

Portfolio Pulse from Benzinga Newsdesk

July 06, 2023 | 11:03 am